Pharmaceutical manufacturing facility to be built in Zavolzhye Industrial Park

The investment agreement was signed by the head of the region Sergey Morozov, Sergey Vasin (CEO of the Ulyanovsk Region Development Corporation) and Samir Shrivastava (Director of Springborn Management and Trading). The event took place at the forum in Sochi on 14 February.

 

“Zavolzhye industrial park is the symbol of the region. Our partners from Germany, Japan, Mexico, France, the USA, Denmark and Turkey have already enjoyed benefits of working here. Today yet another company has chosen this platform. It will manufacture pharmaceutical products – oncological agents and substances – in the territory of the park. Investment into the project will exceed 900 million rubles and about 150 jobs will be created for inhabitants of the region”, - noted the head of the region Sergey Morozov.

The head of the region signed the memorandum on implementation of the investment project during his working trip to the UK last November.

“We are planning that approximately 120-150 people will work at the enterprise. We will manufacture about fifty types of agents; twenty of them are used to treat oncological diseases. About three years ago, we purchased a plant in the Tver region and started working there. Then we understood that we need another plant. We have been studying this issue for a long time and considered different regions. The Ulyanovsk region offered the best conditions”, – said Samir Shrivastava, Director of Springborn Management and Trading is a pharmaceutical company which primary activity is development and fully integrated production of         generic medical product. Manufacturing facilities are located in Redkino, an urban-type settlement in Konakovo District, Tver region. The company operates in accordance with the license for production of pharmaceuticals.

“Earlier we have been engaged in intensive negotiations with one Baltic company and even selected a suitable land plot in Zavolzhye Park. However, they decided against working at the Russian market due to the sanctions. We continued looking for the investor and found an Indian-British enterprise that has good experience in production of pharmaceuticals”, – Sergey Vasin noted.

As a reference:

Springborn Management and Trading is a pharmaceutical company which primary activity is development and fully integrated production of generic medical product. Manufacturing facilities are located in Redkino, an urban-type settlement in Konakovo District, Tver region. The company operates in accordance with the license for production of pharmaceuticals.

 

 

25.02.19